Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech

episode

Bloomberg Businessweek not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

Telltales, Traitors Producer and 1987. 54 min · 22 Sep 2026 · Ray D'Arcy Daily

Meta Shares Rally on Muse Success, Shopify Deal 2 min · 22 Sep 2026 · WSJ Minute Briefing

Fresh Take – the best movie reboots 11 min · 22 Sep 2026 · Today with David McCullagh

Tech rally takes a breath 4 min · 22 Sep 2026 · Wall Street Breakfast

Eoin McGee answers your money questions 22 min · 22 Sep 2026 · Today with David McCullagh

Are You Sacrificing Your Kids At The Woke Altar? 21 min · 22 Sep 2026 · Politics By Faith w/Mike Slater

Report any issue

Source

Recorded26 Jun 2017

Publisheromnycontent.com ↗

Handlerec:3282961

Show notes

Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: David Nierengarten Head of Health Care Equity Research Wedbush Securities Discussing investing in biotech stocks, inlcuding Blueprint Medicines.See omnystudio.com/listener for privacy information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related